Improving risk prediction in heart failure: Maggic + natriuretic peptides

Document Type

Conference Proceeding

Publication Date


Publication Title

J Card Fail


Background: Risk stratification of patients with heartfailure (HF) remains challenging but is a critical need. The MAGGIC score is a clinical risk model derived from meta-analysis of nearly 40k patients. Natriureticpeptides (NP) have consistently shown powerful riskprediction in HF patients, but the incremental value in addition to MAGGIC score is not known. Methods: In this single center study 4264 patients were analyzed from two cohorts; a prospective ambulatory registry of HF patients (n = 1314) who had baseline NTproBNP levels measured, and a retrospective cohort collected utilizing administrative data from hospital discharges for HF (January 1st, 2014 through July 30th, 2015; n = 2503) with clinical BNP levels measured at or near discharge. The hospital discharge cohort were all assigned NYHA class IV. The primary end-point was all cause mortality. Performance of the MAGGIC score and NP levels was assessed within each cohort utilizing Cox regression and receiver operating curves (ROC) analysis (MAGGIC alone vs. MAGGIC+NP) with the net reclassification improvement (NRI) also calculated. Results: The overall cohort had an average age of 71.2 years, was 47.8% females, and 41% self-identified African Americans. Median follow up was 1.52 years during which there were 1139 deaths (27%). The MAGGIC score was a strong predictor of outcome in both cohorts (P < .001). In ROC analysis of the ambulatory registry, NP significantly improved area under the curve (AUC) compared to MAGGICalone from 0.74 to 0.79 (P = .002) and had a NRI of 0.354 (Figure). In contrast, within the hospital discharge cohort NP levels did not significantly add to MAGGIC score (AUC 0.681 vs. 0.676, NRI = 0.033, P = .284) (Figure). Conclusion: In our study, NP levels inthe ambulatory setting significantly improved riskstratification provided by the MAGGIC score, but discharge NP levels did not improve MAGGICprediction of posthospital survival. Overall riskstratification and particularly NP utility is much better in the ambulatory setting. (Figure Presented).



First Page


This document is currently not available here.